Knight Therapeutics Announces Relaunch of ORGOVYX® in Canada
MONTREAL, Oct. 07, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has relaunched ORGOVYX® (relugolix) in Canada. In June 2024, Knight and Sumitomo Pharm
(Financial Post, 2025-10-07T11:30:47Z)